Santa Clara / Austin / Toronto / San Jose / St. Louis / Palo Alto / Vedbaek / Kingston / Cambridge / Foster City / San Diego / /
Company
Affymetrix Inc. / Cell Signaling Technology Inc. / Nordion International Inc. / Hui AB / Macmillan Publishers Limited / Dharmacon Inc. / Roche Diagnostics / Agilent / Qiagen / Bio-Rad Laboratories / PcG / Agilent Technologies Inc. / Applied Biosystems Inc. / Microsoft Inc. / Bio-Rad / Bristol-Myers Squibb Canada / Tomlins SA / Upstate Biotechnology Inc. / Invitrogen Corp. / Exiqon Inc. / Becton Dickinson / Creative Commons / /
Country
Canada / Denmark / United States / /
Currency
pence / / /
Event
FDA Phase / /
Facility
University Health Network / Ontario Cancer Institute / Campbell Family Institute / Princess Margaret Hospital / University Health Network Microarray / PRC2 complex / University Avenue / University of Toronto / Princess Margaret Hospital/Ontario Cancer Institute / /
IndustryTerm
utilized miR target prediction algorithms / open software development / therapy for early disease / stock solution / polycomb / biological systems / diagram tool / archival bank / published protocol / functionalannotation tools / biochemical tools / reverse transfection protocol / performed using DAVID Bioinformatics Database functionalannotation tools / /
MarketIndex
set 10 / /
MedicalCondition
primary nasopharyngeal carcinoma / formalin-fixed paraffin-embedded breast cancer / prostate cancer / FFPE tumor / tumor nuclear immunostaining / tumor / Cancer / nasopharyngeal carcinoma / recurrent nasopharyngeal carcinoma / tumors / mutant vesicular stomatitis virus / epithelial cancers / murine mammary tumors / distant metastases / locally advanced disease / patient tumors / kidney cyst / colorectal cancer / solid tumors / human cancers / early-stage disease / J Cancer / early disease / acute promyelocytic leukemia / Disease / human nasopharyngeal carcinoma / aggressive breast cancer / female SCID / delayed tumor / SCID / both cancer / /
Division of Applied Molecular Oncology / University of Toronto / Toronto / Department of Radiation Oncology / Campbell Family Institute for Cancer Research / Ministry of Health / Animal Care Committee / Margaret Hospital / Princess Margaret Hospital/Ontario Cancer Institute / Princess Margaret Hospital / Ontario Cancer Institute / Avni O. Unconventional association / /
Person
Mariano Elia Chair / Gordon Tozer / Ding I. Pathophysiological / Van Ness / David J / / /
Position
Champagne MP / RT / Representative / Canada *Corresponding author / Extractor / disease model / a comprehensive analysis / Cao / Chair / reporter / /
Product
Sigma / glycine / penicillin / EZH2 / C666-1 / /
ProvinceOrState
Quebec / Ontario / /
PublishedMedium
the Ministry / Cancer Research / /
Technology
radiation / siRNA / stem cells / Human Genome / apoptosis / DNA Chip / gene expression / chemotherapy / reverse transfection protocol / three algorithms / bioinformatics / previously published protocol / electrophoresis / microwave / cloning / commonly utilized miR target prediction algorithms / scored using a previously published protocol / /
Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98